Evidence map›Paper›PMID 40667484›Full record

ArticleOpen life sciences2025

Fabrication of zinc oxide nanoparticles using

Xianglin Guo, Haiyan Qu, Xiaoxu Lin, Zhengxiang Guo, Han Xia

Abstract read
In one paragraph

Article in Open life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xianglin GuoDepartment of Urologic/Thyroid Surgery, Yantaishan Hospital, Yantai, Shandong, 264000, China.
Haiyan QuDepartment of Urology, Huaian Hospital of Huaian City, Huaian, Jiangsu, 223200, China.
Xiaoxu LinHemodialysis Room, Yantaishan Hospital, Yantai, Shandong, 264000, China.
Zhengxiang GuoDepartment of Nursing, Huaian Hospital of Huaian City, Huaian, Jiangsu, 223200, China.
Han XiaDepartment of Cardiovascular Medicine, The People's Hospital of Dazu, Chongqing, 402360, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of plant-based medicines for the production of green nanomaterials represents a viable route for cancer treatment. In this study, we report a novel method for the biosynthesis of zinc oxide nanoparticles (ZnO NPs) using the leaf extract of

Indexed as

anticancer activityantioxidantP53/STAT3 pathwayR. tuberosaZnO NPs

Identifiers

PMID40667484
PMCPMC12260351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.